Results 231 to 240 of about 1,643,238 (355)

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Relationship Between Depression and Decreased Activity Level and Cognitive Impairment in Patients with Diabetes Mellitus Type 2 and/or Atrial Fibrillation. [PDF]

J Clin Med
Militaru M, Lighezan DF, Tudoran C, Zara F, Bucur A, Militaru AG.   +5 more
europepmc   +1 more source

Exploration on significance of platelet cd62p, cdp63 determination in type 2 diabetes mellitus patients with blood stasis syndrome [PDF]

, 2000
Zhaoshun Jiang, Shenglan Zhang, Tianqin Kou, Xing Wanjia, Hui ying Yan, Geping Yin   +5 more
openalex   +1 more source

Effectiveness and safety of combining thiazides with loop diuretics vs. loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study investigated factors associated with and outcomes of combined loop diuretics with hydrochlorothiazide (HCTZ) for acute decompensated heart failure (ADHF). Methods In this retrospective study, adults hospitalized for ADHF and who received intravenous loop diuretics between January 2016 and March 2023 were enrolled.
Chia‐Chen Hsu, Hsien‐Chih Chiu, Ju‐Chieh Wung, Yueh‐Ching Chou, Yuh‐Lih Chang, Chian‐Ying Chou, Chin‐Chou Huang   +6 more
wiley   +1 more source

Global burden of polycystic ovary syndrome, uterine cancer and diabetes mellitus type 2 among women of childbearing age: trends in incidence, prevalence, mortality, and disability-adjusted life-years from 1990 to 2021. [PDF]

Front Med (Lausanne)
Xie MZ, Qin M, Yang Z, Huang R, Qin R.
europepmc   +1 more source

Neuropathic sensory symptoms did not accurately detect polyneuropathy in type 2 diabetes mellitus [PDF]

, 2000
Simon J. Griffin
openalex   +1 more source

Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women.

Journal of the National Cancer Institute, 1999
F. Hu, J. Manson, Simin Liu, D. J. Hunter, Graham A Colditz, K. Michels, F. Speizer, E. Giovannucci   +7 more
semanticscholar   +1 more source

Why and how do we perform physical examination(s) in clinical trials? A use case of drug intervention trials in type 2 diabetes mellitus

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study was to determine the purpose and use of physical examination (PE) in phase 3 and 4 drug interventional clinical trials within type 2 diabetes mellitus. Methods A total of 226 clinical trial protocols identified from the ClinicalTrials.gov database were systematically reviewed by five researchers.
Julia Kopanz, Amy Rogers, Lina Pérez‐Breva, Emily Hall, Prashasthi Devaiah, Isla S. Mackenzie, Bart Lagerwaard, Diederick E. Grobbee, Mira G. P. Zuidgeest, on behalf of the Trials@Home consortium   +9 more
wiley   +1 more source

Characterization of an Early Decline in Baseline Plasma Glucose Concentration after Acute Insulin Elevation during Euglycemic Hyperinsulinemic Clamp in Patients with Type 2 Diabetes Mellitus.

, 2000
Taro Wasada, Hiroyuki Kuroki, HIROKO ARII, Akiko Satô, Kozo Katsumori, S Saito, Yasuhiko Iwamoto   +6 more
openalex   +2 more sources

Is All Coronary Heart Disease Prevention in Type 2 Diabetes Mellitus Secondary Prevention? [PDF]

, 2000
S. M. Haffner
openalex   +1 more source